Related Experiment Video

Updated: Jun 24, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Interventions for anemia in pediatric cancer patients

Antonio Ruggiero1, Riccardo Riccardi

  • 1Department of Pediatrics, Division of Pediatric Oncology, Catholic University of Rome, Rome, Italy.

Medical and Pediatric Oncology
|August 31, 2002
PubMed

Insights

Anemia is common in pediatric cancer patients, often treated with blood transfusions. Epoetin alfa shows promise as an alternative treatment to improve hemoglobin levels and outcomes in these children.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Cancer Treatment Complications

Background:

  • Anemia is a frequent complication in children with cancer, stemming from the disease and its treatments.
  • Anemia is often undertreated until severe (hemoglobin
  • Blood transfusion use escalates with chemotherapy intensity, highlighting a need for alternative therapies.

Purpose of the Study:

  • To evaluate the potential of recombinant human erythropoietin (epoetin alfa) as a treatment for anemia in pediatric cancer patients.
  • To explore alternatives to blood transfusions for managing anemia in this population.
  • To assess the efficacy and safety of epoetin alfa in children with cancer.

Main Methods:

  • Retrospective survey of 74 pediatric cancer patients.
  • Analysis of blood transfusion rates based on chemotherapy intensity.
  • Review of existing data on epoetin alfa use in adults and limited pediatric trials.

Main Results:

  • Blood transfusion rates were significantly higher in children receiving intensive chemotherapy (59.5%) compared to standard chemotherapy (12.5%).
  • A notable percentage of children undergoing intensive chemotherapy did not receive treatment for anemia, despite its high incidence.
  • Epoetin alfa has demonstrated efficacy in adults for increasing hemoglobin and improving quality of life and survival.

Conclusions:

  • Epoetin alfa presents an attractive therapeutic option for anemia in pediatric cancer patients, given its success in adults and the limitations of transfusions.
  • Ongoing clinical studies are crucial to confirm the efficacy and safety of epoetin alfa in this vulnerable patient group.
  • Further research is needed to establish epoetin alfa as a standard treatment for anemia in pediatric oncology.
Abstract

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...